Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Héctor Adrián Cuello"'
Autor:
Marcelo D. Guthmann, Daniel F. Alonso, Ignacio A. Demarco, Marina Albertó, Mariano Rolando Gabri, Cynthia A. Gulino, Cecilia Venier, Héctor Adrián Cuello, Valeria Inés Segatori
Publikováno v:
Cancer Immunology, Immunotherapy. 67:1285-1296
Antitumor strategies based on positive modulation of the immune system currently represent therapeutic options with prominent acceptance for cancer patients’ treatment due to its selectivity and higher tolerance compared to chemotherapy. Racotumoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a08b655e9fc5ba54af8ae7a387b288a
https://doi.org/10.1007/s00262-018-2188-y
https://doi.org/10.1007/s00262-018-2188-y
Autor:
Gretel M. Ferreira, Mariano R. Gabri, Selene Rojo, Valeria Inés Segatori, Héctor Adrián Cuello, Daniel A. Alonso, Cynthia A. Gulino, Carla S. Capobianco
Publikováno v:
Cancer Research. 80:6648-6648
N-glycolylneuraminic acid (NeuGc) is a sialic acid molecule present in mammalian cells as terminal constituents of membrane glycoconjugates such as gangliosides and glycoproteins. Although the role of NeuGc-containing glycoconjugates in human cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29c7e44e2958749b657896cf54214072
https://doi.org/10.1158/1538-7445.am2020-6648
https://doi.org/10.1158/1538-7445.am2020-6648
Autor:
Alejandro Gomez Toledo, Jeffrey D. Esko, Gregory J. Golden, Héctor Adrián Cuello, Victor Nizet
Publikováno v:
The FASEB Journal. 34:1-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb80a2723ca5adbacdeeca4a73265945
https://doi.org/10.1096/fasebj.2020.34.s1.00681
https://doi.org/10.1096/fasebj.2020.34.s1.00681
Autor:
Daniel F. Alonso, Marina Albertó, Mariano R. Gabri, Cynthia A. Gulino, Sandra Camarero, Fabiana Lubieniecki, Laura Galluzzo Mutti, Kevin P. Madauss, Héctor Adrián Cuello, Valeria Inés Segatori, Rosario Aschero
Publikováno v:
Oncotarget
Neuroblastoma (NB) is the most common pediatric malignancy diagnosed before the first birthday in which MYCN oncogene amplification is associated with poor prognosis. Although aberrant glycosylation is an important actor in cell biology, little is kn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9831e66decb160b5b8b0e111abb81779
https://pubmed.ncbi.nlm.nih.gov/30344930
https://pubmed.ncbi.nlm.nih.gov/30344930
Autor:
Daniel F. Alonso, Marina Albertó, Héctor Adrián Cuello, Analía Pesce, Valeria Inés Segatori, Mariano R. Gabri
Publikováno v:
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy. 30(3)
BACKGROUND:Biosimilars are described as biological products that resemble the structure of original biologic therapeutic products, with no clinically meaningful differences in terms of safety and effectiveness from the original. A wide range of biosi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c692a68696dd2548843f9a2e582a92b3
https://pubmed.ncbi.nlm.nih.gov/27053342
https://pubmed.ncbi.nlm.nih.gov/27053342
Autor:
Daniel F. Alonso, Cynthia A. Gulino, Marina Albertó, Héctor Adrián Cuello, Valeria Inés Segatori, L. Galluzzo Mutti, Mariano R. Gabri, Fabiana Lubieniecki, Kevin P. Madauss, Rosario Aschero
Publikováno v:
ESMO Open. 3:A111
Introduction Glycans are diverse and complex molecules with a crucial participation in critical events of cell biology. Their implications in adult cancer are widely reported, but little is known about their role in paediatric cancer such as Neurobla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd9d5ccf70dfe093f5cbd28bb0e9e923
https://doi.org/10.1136/esmoopen-2018-eacr25.266
https://doi.org/10.1136/esmoopen-2018-eacr25.266